FDA puts partial hold on clinical trials of AbbVie's cancer drug

FILE PHOTO: A trader works by the post that trades AbbVie on the floor of the New York Stock Exchange March 5, 2015. REUTERS/Brendan McDermid

Data review from the trial showed a higher number of deaths among patients taking Venclexta, compared to those given a placebo alongside other treatment. Patients who are currently enrolled in studies and receiving the therapy may continue with the treatment, but no new patients should be enrolled in trials testing Venclexta for multiple myeloma until a further analysis of the data is completed, the drugmaker said.

My sister has this disease. Its always profits over people.

“Data review from the trial showed a higher number of deaths among patients taking Venclexta, compared to those given a placebo alongside other treatment.”

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Altria shares hit after National Cancer Institute director named acting head of the FDAAltria investors don't seem to like the prospects for the cigarette maker under the new acting FDA commissioner. Mavi dostum 💙😂😂teşekkürler anladım ben 😉
Source: CNBC - 🏆 12. / 72 Read more »

The New Acting Chief Of The FDA Is A Cancer ScientistNorman 'Ned' Sharpless has publicly supported the agency's policies to curb the use of e-cigarettes. Actually qualified?
Source: BuzzFeed - 🏆 730. / 51 Read more »